Full Press Release Details
AC Immune Opens New Centers in Phase 1b 2 Trial Evaluating ACI 24 Targeting Abeta in Alzheimer s Disease And Down Syndrome.
ACIU
AC Immune Opens New Centers in Phase 1b 2 Trial Evaluating ACI 24 Targeting Abeta in Alzheimer s Disease And Down Syndrome
Key Takeaway: AC Immune Opens New Centers in Phase 1b 2 Trial Evaluating ACI 24 Targeting Abeta in Alzheimer s Disease And Down Syndrome